September 2019

Osteopore Ltd (ASX: OSX)

Osteopore Ltd (ASX: OSX), an innovative medical technology company in Singapore is now publicly listed and traded on the Australian Stock Exchange (ASX). OSX raised AU$5.25 million from a number of institutional, high net worth and sophisticated individuals at AU$0.20 per share and a market cap of AU$20.2 million.

Round Table subscribed to OSX at AU$0.20.

OSX traded strongly on its first day of listing to the peak of AU$1.225 on the 25th of September 2019, bringing a staggering 517% growth on AU$0.20 shares initially subscribed by Round Table’s directors. Price retraced and normalised over the last week of September and continues to show signs of great strength during market open on 1st October 2019.

Since its inception, Osteopore has accumulated a long track record of successful 10-year clinical outcomes, awards, certifications and recognition for its innovation.

Mediland Pharm Ltd (ASX: MPH)

The Directors of Round Table is announcing a complete exit of all its holding positions in Mediland Pharm Ltd (ASX: MPH)

Round Table’s directors subscribed to MPH at AU$0.20, which began trading on the final week of February 2019 at the IPO price of A$0.20 per share. They have since relinquished all open positions with an average profit of 80% from entry.